Heramed Ltd - Asset Resilience Ratio

Latest as of December 2024: 0.83%

Heramed Ltd (HMD) has an Asset Resilience Ratio of 0.83% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Heramed Ltd (HMD) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

AU$23.01K

≈ $16.28K USD Cash + Short-term Investments

Total Assets

AU$2.78 Million

≈ $1.96 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2024)

This chart shows how Heramed Ltd's Asset Resilience Ratio has changed over time. See Heramed Ltd (HMD) shareholders funds for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Heramed Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Heramed Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$0.00	0%
Short-term Investments	AU$23.01K	0.83%
Total Liquid Assets	AU$23.01K	0.83%

Asset Resilience Insights

Limited Liquidity: Heramed Ltd maintains only 0.83% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Heramed Ltd Industry Peers by Asset Resilience Ratio

Compare Heramed Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Vitrolife AB ST:VITR	Medical Devices	7.27%
Medprin Regenerative Medical Technologies Co. Ltd. SHE:301033	Medical Devices	19.31%
Tellgen Corp SHE:300642	Medical Devices	8.60%
Lumos Diagnostics Holdings Ltd AU:LDX	Medical Devices	9.40%
T&R Biofab Co. Ltd KQ:246710	Medical Devices	0.12%
Ok Biotech Co Ltd TW:4155	Medical Devices	0.32%
Promimic AB ST:PRO	Medical Devices	8.62%
Memphasys Ltd AU:MEM	Medical Devices	0.00%

Annual Asset Resilience Ratio for Heramed Ltd (2017–2024)

The table below shows the annual Asset Resilience Ratio data for Heramed Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.83%	AU$23.01K ≈ $16.28K	AU$2.78 Million ≈ $1.96 Million	-0.63pp
2023-12-31	1.46%	AU$29.38K ≈ $20.79K	AU$2.01 Million ≈ $1.43 Million	+0.92pp
2022-12-31	0.54%	AU$22.51K ≈ $15.93K	AU$4.19 Million ≈ $2.96 Million	-0.01pp
2021-12-31	0.55%	AU$25.27K ≈ $17.88K	AU$4.57 Million ≈ $3.24 Million	-0.68pp
2020-12-31	1.23%	AU$39.06K ≈ $27.64K	AU$3.17 Million ≈ $2.25 Million	+0.22pp
2019-12-31	1.02%	AU$36.61K ≈ $25.90K	AU$3.61 Million ≈ $2.55 Million	+0.85pp
2018-12-31	0.16%	AU$6.86K ≈ $4.85K	AU$4.27 Million ≈ $3.02 Million	-0.24pp
2017-12-31	0.40%	AU$5.00K ≈ $3.53K	AU$1.25 Million ≈ $882.84K	--

pp = percentage points

About Heramed Ltd

AU:HMD Australia Medical Devices

Market Cap

$37.04 Million

AU$52.34 Million AUD

Market Cap Rank

#22962 Global

#875 in Australia

Share Price

AU$0.05

Change (1 day)

-6.00%

52-Week Range

AU$0.01 - AU$0.05

All Time High

AU$0.32